Max Healthcare Institute Limited (MAXHEALTH) - Net Assets
Based on the latest financial reports, Max Healthcare Institute Limited (MAXHEALTH) has net assets worth Rs107.47 Billion INR (≈ $1.16 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs172.31 Billion ≈ $1.86 Billion USD) and total liabilities (Rs64.84 Billion ≈ $701.25 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Max Healthcare Institute Limited (MAXHEALTH) strategic investment index to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs107.47 Billion |
| % of Total Assets | 62.37% |
| Annual Growth Rate | 28.13% |
| 5-Year Change | 71.06% |
| 10-Year Change | 871.71% |
| Growth Volatility | 127.69 |
Max Healthcare Institute Limited - Net Assets Trend (2014–2026)
This chart illustrates how Max Healthcare Institute Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of Max Healthcare Institute Limited.
Annual Net Assets for Max Healthcare Institute Limited (2014–2026)
The table below shows the annual net assets of Max Healthcare Institute Limited from 2014 to 2026. Also explore Max Healthcare Institute Limited net asset momentum to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs107.47 Billion ≈ $1.16 Billion |
+14.56% |
| 2025-03-31 | Rs93.81 Billion ≈ $1.01 Billion |
+11.57% |
| 2024-03-31 | Rs84.08 Billion ≈ $909.31 Million |
+13.48% |
| 2023-03-31 | Rs74.10 Billion ≈ $801.32 Million |
+17.94% |
| 2022-03-31 | Rs62.82 Billion ≈ $679.43 Million |
+11.42% |
| 2021-03-31 | Rs56.39 Billion ≈ $609.80 Million |
+471.06% |
| 2020-03-31 | Rs9.87 Billion ≈ $106.78 Million |
+2.51% |
| 2019-03-31 | Rs9.63 Billion ≈ $104.17 Million |
-6.85% |
| 2018-03-31 | Rs10.34 Billion ≈ $111.82 Million |
-6.51% |
| 2017-03-31 | Rs11.06 Billion ≈ $119.60 Million |
-1.97% |
| 2016-03-31 | Rs11.28 Billion ≈ $122.01 Million |
+30.74% |
| 2015-03-31 | Rs8.63 Billion ≈ $93.32 Million |
+57.19% |
| 2014-03-31 | Rs5.49 Billion ≈ $59.37 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Max Healthcare Institute Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4809850000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs43.96 Billion | 40.91% |
| Common Stock | Rs9.73 Billion | 9.06% |
| Other Comprehensive Income | Rs1.39 Billion | 1.29% |
| Other Components | Rs52.38 Billion | 48.74% |
| Total Equity | Rs107.47 Billion | 100.00% |
Max Healthcare Institute Limited Competitors by Market Cap
The table below lists competitors of Max Healthcare Institute Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Dr. Reddy’s Laboratories Ltd ADR
NYSE:RDY
|
$11.16 Billion |
|
Nordex SE
F:NDX1
|
$11.17 Billion |
|
JAMES HARDIE INDUST.ADR/1
F:JHA0
|
$11.18 Billion |
|
Eurofins Scientific SE
F:ESF0
|
$11.18 Billion |
|
Zebra Technologies Corporation
NASDAQ:ZBRA
|
$11.16 Billion |
|
TELECOM ITALIA ADR 1
F:TQIA
|
$11.15 Billion |
|
Smurfit Kappa Group PLC
F:SK3
|
$11.14 Billion |
|
SG Micro Corp
SHE:300661
|
$11.12 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Max Healthcare Institute Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 93,808,700,000 to 107,466,300,000, a change of 13,657,600,000 (14.6%).
- Net income of 14,424,100,000 contributed positively to equity growth.
- Dividend payments of 1,456,200,000 reduced retained earnings.
- New share issuances of 338,200,000 increased equity.
- Other comprehensive income increased equity by 255,300,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs14.42 Billion | +13.42% |
| Dividends Paid | Rs1.46 Billion | -1.36% |
| Share Issuances | Rs338.20 Million | +0.31% |
| Other Comprehensive Income | Rs255.30 Million | +0.24% |
| Other Changes | Rs96.20 Million | +0.09% |
| Total Change | Rs- | 14.56% |
Book Value vs Market Value Analysis
This analysis compares Max Healthcare Institute Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.64x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 79.74x to 9.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | Rs13.29 | Rs1059.90 | x |
| 2015-03-31 | Rs19.13 | Rs1059.90 | x |
| 2016-03-31 | Rs20.67 | Rs1059.90 | x |
| 2017-03-31 | Rs20.27 | Rs1059.90 | x |
| 2018-03-31 | Rs18.95 | Rs1059.90 | x |
| 2019-03-31 | Rs17.65 | Rs1059.90 | x |
| 2020-03-31 | Rs18.38 | Rs1059.90 | x |
| 2021-03-31 | Rs65.32 | Rs1059.90 | x |
| 2022-03-31 | Rs64.81 | Rs1059.90 | x |
| 2023-03-31 | Rs76.25 | Rs1059.90 | x |
| 2024-03-31 | Rs86.20 | Rs1059.90 | x |
| 2025-03-31 | Rs96.00 | Rs1059.90 | x |
| 2026-03-31 | Rs109.91 | Rs1059.90 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Max Healthcare Institute Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.42%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.23%
- • Asset Turnover: 0.49x
- • Equity Multiplier: 1.60x
- Recent ROE (13.42%) is above the historical average (3.57%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -11.78% | -6.85% | 0.74x | 2.33x | Rs-1.20 Billion |
| 2015 | -4.42% | -4.83% | 0.53x | 1.73x | Rs-1.24 Billion |
| 2016 | -2.00% | -1.58% | 0.47x | 2.70x | Rs-1.35 Billion |
| 2017 | 1.43% | 0.98% | 0.51x | 2.85x | Rs-948.05 Million |
| 2018 | -2.01% | -1.20% | 0.52x | 3.21x | Rs-1.24 Billion |
| 2019 | -0.31% | -0.18% | 0.50x | 3.49x | Rs-993.29 Million |
| 2020 | 5.97% | 5.57% | 0.28x | 3.87x | Rs-397.51 Million |
| 2021 | -2.44% | -5.48% | 0.29x | 1.52x | Rs-7.01 Billion |
| 2022 | 9.63% | 15.37% | 0.43x | 1.46x | Rs-231.97 Million |
| 2023 | 14.89% | 24.19% | 0.45x | 1.36x | Rs3.63 Billion |
| 2024 | 12.58% | 19.56% | 0.45x | 1.43x | Rs2.17 Billion |
| 2025 | 11.47% | 15.31% | 0.46x | 1.62x | Rs1.38 Billion |
| 2026 | 13.42% | 17.23% | 0.49x | 1.60x | Rs3.68 Billion |
Industry Comparison
This section compares Max Healthcare Institute Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $13,499,628,556
- Average return on equity (ROE) among peers: 3.85%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Max Healthcare Institute Limited (MAXHEALTH) | Rs107.47 Billion | -11.78% | 0.60x | $11.16 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $29.95 Billion | 11.35% | 0.79x | $14.10 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $38.34 Billion | 3.85% | 2.04x | $4.25 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.69 Billion | 15.67% | 0.72x | $143.31 Million |
| Healthcare Global Enterprises Limited (HCG) | $7.14 Billion | -27.10% | 1.85x | $1.15 Billion |
| Jupiter Life Line Hospitals Limited (JLHL) | $13.56 Billion | 14.24% | 0.40x | $971.61 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $1.92 Billion | 9.82% | 1.94x | $3.45 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $176.82 Million | 7.14% | 0.57x | $25.92 Million |
| Max India Limited (MAXIND) | $14.21 Billion | -2.98% | 0.65x | $91.25 Million |
| Global Health Limited (MEDANTA) | $13.50 Billion | 2.69% | 0.98x | $4.35 Billion |
About Max Healthcare Institute Limited
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, bone marrow transplant, bariatric/weight loss surgery, gynecology, minimal access/laparoscopic surgery, eye care/ophthalmology, r… Read more